Similarly, we observed a significant reduction in ZNF184 protein levels in the cortex (CTX) and a tendency toward a decrease in the SN of human PD patients compared to control subjects (CTL) (Figs 1g and 1h). Here, ZNF184 is linked to Parkinson disease.